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Abstract		
Membrane-nanoparticle	interactions	are	important	in	determining	the	effects	of	manufactured	
nanomaterials	on	cell	physiology	and	pathology.	Here	Silica,	titanium,	zinc,		and	magnesium	oxide	
nanoparticles	were	screened		against		human	hERG	(Kv11.1)	voltage	gated	potassium	channels	
under	whole-	cell	voltage	clamp.		10	µg/ml	ZnO	uniquely	increased	the	amplitude	of	the	steady	
state	current,	decreased	the	rate	of	hERG	current	inactivation	during	steady	state	depolarization,	
accelerated	channel	deactivation	during	resurgent	tail	currents,	and	showed	no	significant	
alteration	of	current	activation	rate	or	voltage	dependence.		In	contrast,	ZnCl2	caused	increased	
current	suppression	with	increasing	concentration	and	failed	to	replicate	the	nanoparticle	effect	on	
decreasing	inactivation.	The	results	show	a	novel	class	of		nanoparticle-biomembrane	interaction	
involving	channel	gating	rather	than	channel	block,		and	have	implications	for	the	use	of	
nanoparticles	in	biomedicine,		drug	delivery	applications	and	nanotoxicology.		
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Introduction	
As	engineered	nanoparticles	are	increasingly	used	in	multiple	applications	in	manufacturing,	and	
biomedicine,	their	unique	surface	to	volume	ratios,	chemical	composition	and	diversity	means	
that	their	potential	interactions	with	biological	processes	needs	to	be	continually	assessed[1].	With		
the	downstream	effects	of	nanoparticle	exposure	on	cell	toxicity		becoming	clearer	[2],		the		first	
site	of	contact	of	nanoparticles	with	cells		through	attachment	to,	modification	of,	or	penetration	
through,		lipid	bilayers	and	interaction	with	their	constituent	intramembrane	proteins	has	received	
increasing	attention.	Cationic	nanoparticles	are	capable	of	inducing	nanometer	sized	holes	in	
supported	(artificial)[3]	and		naturally	occurring	lipid	bilayers	[4].		In	addition,	cationic	and	anionic	
nanoparticles	are	able	to	induce	local	membrane	fluidity	and	gelation	in	lipid	bilayers	respectively	
when	they	bind	to	the	bi-layer	surface	[5].			As	a	result	of	hole	formation,		NPs	may	also	pass	
through	the	membrane	in	a	manner	that	is	independent	of	endo-	or	pinocytotic	pathways[6].				
Cellular	lipid	bilayers	also	contain	membrane	proteins,		and	nanoparticles		also	interact	with	these	
components	in		species	dependent	ways.			Small	gold	nanoparticles		directly		block	ion	-channels[7],		
and		cell	excitability	is	altered	by	the	presence	of	ZnO[8]		and	nano-Ag[9]		in	the	bathing	solution.	
Other	particles,		while		cytotoxic,			do	not	interfere	with	channel	function[10].		Interpretation	of	
nanoparticle		effects	are	also	complicated		by	nanoparticle	behavior	in	biological	solutions,	where	
action	could	be	due		to	their	intrinsic	chemistry,				genuine	‘Nano’	effects,	or	changes	due	to	
sedimentation	and	diffusion	of	the	particles[1,11].			
To	try	to	address	these	issues	directly,	we	characterized	and	screened	a	series	of	engineered	
nanoparticles	(SiO2,	ZnO,	MgO,	TiO2)		against	a	model	human	ion	channel		(hERG	potassium	
channel)	to	determine	if	there	were	any		nanoparticle	effects	on	membrane	lipids	or	channel	
activity	using	the	whole	cell	voltage	clamp	technique	and	rapid	solution	exchange	(Figure	1).				The	
Voltage	Clamp	method	has	the	advantage	of	continuously	monitoring	membrane	integrity,		
membrane	capacitance	and	is	capable	of	detecting	both	membrane	breakdown	and	alterations	in	
membrane	area	in	an	unambiguous	way.		
Electrophysiological	measurement	of	heterologously	expressed	hERG	channel	activity	represents		
a	standard	drug	screening	assay	which	is	widely	used	to	detect	potentially	harmful	‘off-target’	
drug	effects	[12],			and	has	been	previously	used	in	the	nanotoxicology	context	to	demonstrate	
channel	block	by	ultrafine	gold	nanoparticles	[7]	and	a	lack	of	effect	of	cytotoxic	CdSe	and	
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CdSe/ZnS	particles	[10].		As	hERG	channels		have	a	critical	function	in		shaping	the	cardiac	action	
potential	[13]	,	and	there		is	a	great	deal	of	knowledge	about	hERG	channel	biophysics,	structure[14],	
molecular	biology	and	clinical	impact	[15],	the	channel		presents	itself	as	a		good	candidate	to	use	to	
study	nanoparticle	-ion	channel	interactions.			Using	this	approach	we	measured	membrane	
parameters,	leak	and	potassium	channel	function	on	addition	of	a	panel	of	nanoparticles.	The	
results	show	that	of	all	the	types	of	particle	examined,	ZnO	particles	uniquely	interact	with	the	
hERG	channel	gating	process	with	implications	for	cell	signaling.		
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Methods		
Nanoparticle	Characterization	
The	hydrodynamic	radius	(Z-average)	of		NPs	were	determined	at	20°C	using	a	Zetasizer	Nano	ZS	
ZEN3600	(Malvern	Instruments	Ltd.	Malvern,	UK)	operating	with	a	He-Ne	laser	at	a	wavelength	of	
633	nm	and	measuring	back-scattered	light	at	173°	relative	to	the	incident	beam.		
NPs	were	prepared	by	mixing	2µl	of	the	standard	solution	(1	mg/ml	,	0.1%	W/V)	which	had	been	
sonicated	for	20	minutes,	with	1	ml	of	distilled	water	or	filtered	solutions	(hERG),	vortexed	for	1	
minute	and	transferred	to	a	disposable	folded	capillary	cell.	The	samples	were	run	three	times	with	
one-minute	intervals	between	measurements	for	each	time	point.			Changes	in	particle	diameter	
over	time	was	followed	every	five	minutes	for	1	hr	to	determine	the	likely		behaviour	of	the	
particles	when	added	to	the	experimental	chamber.		Diameters	are	given	in	Table	1	for	one	and	
twenty	minute	time	points	for	each	NP.				
As	it	has	been	reported	that	nanoparticle	preparations	can	have	significant	endotoxin	
contamination	[16],		we	screened	the	nanoparticle	suspensions		in	hERG	solution	at		10	µg/ml	of	NPS	
for	endotoxin	contamination	using	the		LAL	chromogenic	assay	according	to	the	manufacturers’	
instructions		(GenScript,	Piscataway,	USA).	
Electron	Microscopy	
	
To	further	characterize	the	Nanoparticles	in	contact	with	cells,	we	carried	out	Scanning	Electron	
Microscopy	on	fixed	material.	Briefly,	cells	were	plated	onto	coverslips	and	exposed	to	10	µg/ml	of	
nanoparticles	(Control,	SiO2,	ZnO	(MB),	TiO2)	for		twenty	minutes	.		Cells	and	NPS	were	then	fixed	
in		2.5	%	glutaraldehyde	in	0.1	M	phosphate	buffer	at	20	°C	(pH	7.3)	for	20	minutes,	washed	in		0.1	
M	phosphate	buffer	before	immersion	in		1%	OsO4,	for	20	minutes.		Coverslips	were	dehydrated	
through	30%	to		100%	ethanol,		critical	point	dried	and	sputter	coated	with	1-2	nm	gold-palladium.	
Coverslips	were	visualised	on	a		JEOL	6700F	scanning	electron	microscope		(JEOL	USA,	Inc.	
Peabody	USA).	Individual	particle	sizes	were	estimated	by	measuring	the	dimensions	of	single	
nanoparticles	visible	on	cells,	and	on	cell	processes.	
 
Cell	culture	
	
Accepted	version.		Published	online	in	Small	26	February	2018																																																																								DOI	10.1002/smll.201703403	
6	
	
Ready-to-use	‘instant’	cells	were	supplied	in	batch	by	(Cytocentrics,	Db)	and	stored	under	liquid	
nitrogen.	The	HEK239	cells	expressed	the	voltage	sensitive	hERG	K+	channel		(Kv	11.1	KCNH2).	Cells	
were	defrosted	prior	to	use	by	resuspending	them	in	hERG	solution	(see	below	under	
electrophysiology	for	solution	composition),	spun	down	at	1,000	RPM	to	remove	fragments,		
resuspended	in	fresh	hERG	solution	and	plated	onto	glass	cover	slips.	Cells	remained	viable	at	room	
temperature	(20°C)	for	at	least	eight	hours.	
Electrophysiology	
Currents	 were	 recorded	 from	 cells	 at	 room	 temperature	 (20	 °C),	 using	 the	 whole	 cell	 voltage	
clamp	technique.	During	recordings,	cells	were	perfused	continuously	(1	 	ml/minute)	with	 ‘hERG	
solution’		consisting	of		140	mM		NaCl,	2.5	mM	KCl,	2	mM	MgCl2,	2	mM	CaCl2,	10	mM	HEPES,	10	
mM	Glucose,	15	mM	D	 (+)-Saccharose	 	 	 (pH	7.4,	 	320	mOsm/kg).	Electrodes	were	pulled	with	a	
Sutter	 Instruments	 P97	 microelectrode	 puller	 using	 borosilicate	 glass	 capillaries	 (Harvard	
Apparatus	 Ltd),	 and	 filled	 with	 intracellular	 solution	 (100	mM	 K-Gluconate,	 20	mM	 KCl,	 1	 mM	
CaCl2,	 1	 mM	MgCl2,	 10	 mM	 HEPES,	 3	 mM	 Phosphocreatine,	 11	 mM	 EGTA-KOH,	 9	 mM	 D	 (+)-
Sucrose,	4	mM	ATP-Mg	(pH	7.2,	 	295	mOsm/kg).	 	3-5	MΩ	resistance	pipettes	were	brought	 into	
contact	 with	 the	 cell	 surface	 by	 micromanipulation,	 GΩ	 resistance	 cell-attached	 seals	 were	
obtained	 by	 gentle	 suction,	 and	whole–cell	 access	 achieved	 by	 rupturing	 the	 patch	 with	 direct	
suction.	Using	an	Axoclamp	2B	amplifier	and	a	HS-2A-x0.1LU	headstage,	the	cell	was	clamped	to	–
70	mV.	Each	voltage	clamp	protocol	was	preceded	by	a	5	mV		voltage	clamp	step	which	was	used	
later	 to	 calculate	 membrane	 capacitance	 and	 leakage	 currents	 (see	 voltage	 clamp	 protocol	 in	
Figure	2).		Capacitance	(Cm)	was	calculated	according	to	equation	1,	where	Q(t)	is	the	total	charge	
under	the	capacitive	transient	and	ΔV	is	the	amplitude	of	the	voltage	pulse	applied.		
Cm		=	Q(t)/ΔV															(1)	
 
The	calculation	of	Cm	was	carried	out	using	the	membrane	test	feature	of	Clampfit	10	(Molecular	
Devices	Corporation,	1311	Orleans	Dr,	Sunnyvale,	CA	94089,	USA).	Current	and	voltage	outputs	
from	the	amplifier	were	digitized	through	a	Digidata	1322A	digital	acquisition	system	and	stored	on	
an	IBM	PC.	Amplifier,	data	acquisition	system,	and	software	were	all	from	Molecular	Devices	
Corporation		(1311	Orleans	Dr,	Sunnyvale,	CA	94089,	USA).			Cells	with	holding	currents	greater	or	
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equal	to	100	pA	or	that	developed	leakage	during	perfusion	were	rejected.		All	I/V	plot	plots	and	
data	are	presented	with	no	compensation	for	non-linear	leakage	currents.			
Coating	ZnO	NPs	with	serum	protein	
To	examine	the	effect	of	the	generation	of	a	hard	protein	corona[17],		we	incubated	10	µg/ml	
ZnO(MB)	particles	suspended	in	hERG	sln.	in	1%	BSA	(bovine	serum	albumin,		Sigma-Aldrich,	St	
Louis,	USA)	for	20	minutes.		The	resulting	solution	was	perfused	over	the	preparation.		
Alternatively,		hERG	sln.	containing	1%		BSA	was	perfused	over	voltage	clamped	cells	either	in	the	
presence	or	absence	of	ZnO	NPs.		
Lipid	peroxidation	
As	it		has	been	reported	that	10	µg/ml		ZnO	nanoparticles	induce	significant	lipid	peroxidation[18],			
we	induced	massive	lipid	peroxidation	by	exposing		voltage	clamped	cells		to		an	estimated	10	mM		
of	hydrogen	peroxide	(H2O2)	by	adding	10	µl	of	H2O2	to	hERG	solution	just	before	perfusion	over	the	
cells.		Previous	work		has	estimated	that	up	to	200	µM	H2O2		produces	a	maximal	peroxidation	
response	in	human	lymphocytes	over	24	hours[19].			The	most	rapid	effects	of	peroxidation		have		
been	reported	after	3	hours	exposure,	[18]		thus	in	our		experiments,	which	lasted	a	maximum	of	20	
minutes,	changes	could	not	have	been	generated	by	peroxidation.		
Statistics	
Results	were	tested	for	significant	differences	using	Student’s	t-test.		In	the	case	of	comparison	of	
controls	 and	 test	 results	 where	 controls	 had	 been	 conducted	 in	 parallel,	 an	 unpaired	 	 test	 was	
applied,	where	 ‘before’	and	 ‘after’	 results	were	compared	a	paired	 test	was	used.	All	 results	are	
presented	as	mean	and	standard	errors	of	the	mean.		
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Results	
Nanoparticle	characterization		
Table	1	gives	the	identities	and	properties	of	the	Nanoparticles	used	in	this	study	.	It	was	noted	that		
while		TiO2	and	MgO	NPs	aggregated		in	hERG	solution	(this	is	shown	in	Table	1	as	an	increase	in	the	
main	peak	size	with	several	additional	peaks	appearing	in	the	DLS	measurements	with	time	at	over	
50	and	100	nm	respectively),		the	hydrodynamic	diameters	of		the	other	NPs	in	all	cases	were	
remarkably	stable		during	the	time	course	of	the	experiment.		There	was	an	increase	in	diameter	
between	the	manufacturers	primary	particle	sizes	(TEM),			and	the	results	obtained	by	DLS,	
reflecting	the	fact	that	DLS	measures	hydrodynamic	diameter.		The	perfusion	system	ensured	a	
continuous	flow	of	control	and	NP	loaded	solutions	with	a	complete	bath	exchange	every	30s.		This	
approach,	along	with	time-	dependent	DLS	measurements,	partly	mitigated		uncertainties	[11,20]		
about	the	effective	concentration	of	nanoparticles	(continuous	mixing),	though	did	not	avoid	
particle	aggregation.		We	were	concerned	that	some	of	the	NP	effects	could	have	been	due	to	
particle	contamination	with	other	substances.		Endotoxin	contamination	of	NPs	has	been	reported	
to	have	significant	effects	on	cell	physiology	[16].		We	checked	the	levels	of	endotoxin	using	the	LAL	
chromogenic	assay	and	found	that	a	minimal	level	of	endotoxin	was	present	in	the	samples	(below		
0.1EU/ml	Figure	S1).		For	reference,	less	than	0.16	EU/ml	was	shown	to	be	ineffective	in	generating	
endotoxin	stimulated	proliferative	responses,	[16]	so	it	seems	that	the	levels	of	endotoxin	present	in	
the	samples	were		unlikely	to	account	for	any	of	the	observed	effects.		
Electron	microscopy	
Scanning	electron	micrographs	were	taken	of	representative	fixed	HEK	239	cells.		The	results	show	
(Figure	S2)	that	when	compared	to	control	material,	SiO2	particles	form	a	homogeneous	coating	of	
spherical	particles	around	10-12	nm	in	diameter	over	the	entire	surface	of	the	cells.	In	contrast,	ZnO	
particles	can	be	seen	to	adorn	the	cell	surface	in	a	punctate	way,	and		crystal-like	forms	can	be	seen	
adhering	to	the	cell	surface	(particularly	easy	to	see	on		the	cell	processes-arrows).		Finally,	TiO2	
particles	form	clustered	aggregates	on	the	cell	surface.	We	measured	particle	diameter	from	a	
series	of	Scanning	Electron	Micrographs	and	found	(Table	1	column	7),	that	particle	size	was	
remarkably	consistent	and	quite	close	to	the	manufacturers’	measurements.	
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Resurgent	tail	current	analysis	
hERG	currents	were	evoked	from	the	cells	after		stable	voltage	clamp	was	established		by	
standardized	pulse	protocols	(holding	potential	-70	mV,	depolarizing	pulses	between	-30	to	plus	30	
mV,		followed	by	repolarizing	pulses	to	-50	mV	(see	Figure	2A)).		
Key	features	of	this	potassium	channel	behavior	are	an	initial	outward	‘steady-state’	current	that	on	
increasing	depolarization	shows	increasing	inactivation	after	activation	(Figure2),	and	a	distinctive	
‘resurgent’	tail	current	on	repolarization	that	has	a	sigmoidal	current-voltage	relationship	that	was	
well	fit	by	a	Boltzmann	function	(Figure	2B,	black	current-	voltage	relations).			The	resurgent	tail	
current	amplitude	was	used	in	an	initial	screening	for	all	nanoparticles.	Such	cells	were	subject	to	
continuous	perfusion	of	extracellular	solutions	for	20	minutes.	Membrane	capacitance,	leak	current	
(defined	as	the	difference	between	I=0	and	the	holding	current),	steady	state	current,		and	the	
amplitude	of	the	resurgent	tail	current	were		monitored	once	every	minute	before,		during,	and	
after	application	of	NPs	(Figure	3).			
No	significant	rundown	or	alteration	of	hERG	current	properties	(current	amplitudes,	activation	
inactivation	of	resurgent	tail	or	steady	state	currents)	was	observed	under	control	conditions	
(Figure	3A	&	B).	NPs	were	added	to	the	experimental	extracellular	solution		at	dilutions	of	between	
1/1000-100	x	and	were	applied	to	the	system	by	the	perfusion	system.		NPs	were	added	to	the	
bath	perfusion	system	seven	minutes	after	stability	was	obtained.	Neither	SiO2,	TiO2,	nor		MgO				
had	significant	effects	on	resting	membrane	conductance,	leak,	or		the	resurgent	tail	current	
(Figure	S3A).		Figure	3B	shows	the	application	of	SiO2	compared	to	control	(null	addition).		In	
contrast	ZnO	(10	µg/ml),	increased	the	amplitude	of	the	resurgent	tail	current	by	an	average	of	
around	30	%	(Figure	3C).		Even	on	prolonged	washing	this	increase	in	tail	current	amplitude	was	
not	reversible	(not	shown).		We	applied	different	concentrations		of	ZnO	NPs	to	better	understand	
the	dose	response	relationship	in	the	range	of	0.1-100	µg/ml	(Figure	S3B).		The		results	show	an	
increasing	effect	on	increasing	concentration,	but	we	were	unable	to	fit	the	data	well	with	a	
sigmoidal	function.		
Detailed	investigation	of	the	effect	of	ZnO	on	tail	currents	
To	better	understand	the	process	underlying	the	resurgent	tail	current	 increase	on	ZnO	addition,	
an	analysis	of	current	kinetics	was	carried	out.				
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i	Activation	Kinetics	
The	rising	phase	of	the	whole-cell	K+	current	for	the	first	500	ms	after	depolarization	from	-70	mV	
was	well	fit	by	a	single	rising	exponential	function	(formula	2	and	see	Figure	S4A):	
													
	 	 	 	 	 	 (2)	
	
	 	 	
A	time	constant	of	around	35	ms	was	obtained	for	the	rising	phase	and	the	application	of	ZnO	had	
no	discernible	effect	on	current	activation.	Indeed,	the	current	activation	rate	was	unchanged	after	
20	minutes	(Figure	S4B).			
ii		Steady-state	current	
The	steady	state	current	was	measured	0.5	s	before	the	repolarization	phase	(indicated	in	Figure	
4A).	The	addition	of	ZnO	was	found	to	increase	the	steady-	state	current	by	around	100%	(Figure	
4B)	though	with	a	high	degree	of	variability	from	cell	to	cell.			
Control	values	for	the	steady	state	current	were	stable	for	the	duration	of	the	experiment.		This	
increase	in	current	was	clearly	due	to	a	decline	in	the	strong	inactivation	evident	in	the	steady	
state	current	after	the	first	500	ms	of	activation.	A	further	analysis	was	carried	out	to	estimate	how	
the	inactivation	rate	decreased	by	fitting	a	straight	line	to	the	steady-state	current	after	the	
current	peaked	(Figure	S5A).		The	negative	slope	of	the	current	fit	was	transformed	into	a	positive	
slope	by	the	addition	of	ZnO,	while	the	inactivation	rate	in	controls	was	remarkably	stable	over	
time	(Figure	S5B).		This	suggested	that	the	increase	in	the	resurgent	tail	current	was	the	result	of	
an	increase	in	the	steady-state	current	driven	by	a	decrease	in	the	prominent	inactivation	on	
depolarization.				
iii	Resurgent	tail	current	deactivation	
As	the	result	of	kinetic	analysis	suggested	that	the	effect	was	not	due	to	a	change	in	activation	
kinetics	but	rather	a	decrease	in	inactivation,	we	examined	the	deactivation	rate	of	the	resurgent	
tail	currents.		The	tail	currents	were	well	fit	with	a	double	exponential	function	consisting	of	fast	
and	slow	components.		In	control	material	there	was	a	gradual	slowing	of	the	deactivation	rate	
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which	was	reflected	by		an	increase	in	the	time	constant	of	both	fast	and	slow	components	with	
time.		In	contrast	to	this	trend,	both	slow	and	fast	deactivation	rates	became	faster	on	application	
of	ZnO	(Figure	5).	Both	fast	and	slow	deactivation	rates	increased	by	around	60%.		
iv	Current-voltage	relations	
As	the	screening	involved	repeatedly	testing	the	membrane	current	by	stepping	the	membrane	
voltage	to	20	mV	from	-70	mV	over	a	20	minute	period,				a	potential	explanation	for	the	‘increase’	
in	membrane	current	on	ZnO	addition	could	have	been	a	substantial	shift	in	the	current	voltage	
relations	of	the	tail	and	steady-state	currents.	To	examine	this	possibility,		the	current-voltage	
relations	of	the	hERG	resurgent	tail		currents	were	plotted	for	voltage	steps	between	-30-	+30	mV	
in	the	presence	and	absence	of	ZnO	(Figure	S6).		There	was	no	shift	in	normalized	current	voltage	
relations	for	the	tail	currents.	Instead,	the	amplitude	of	the	currents	increased	in	parallel	across	the	
full	voltage	range.	This	confirms	that	the		increase	in	current	cannot	be	explained	by	a	shift	in	
current	voltage	relations.			
Changes	in	the	lipid	environment	around	the	hERG	channel	
As	it	has	been	established	in	artificial	lipid	bilayers	that	addition	of	membrane	penetrating/	
membrane	incorporated	NPs	could	be	detected	by	measuring	membrane	capacitance	(Cm)	[21],			we	
continuously	monitored	Cm	by	applying	a	brief	5	mV	depolarizing	step		as	an	integral	part	of	every	
voltage	clamp	protocol	prior	to	any	voltage	steps		designed	to	evoke	voltage	activated	currents	
(see	e.g.	Figure	2).	This	had	the	additional	advantage	of	allowing		continuous	monitoring	of	
membrane	leak	currents.		The	results	show	(Figure	S7)	that	the	cells	had	a	mean	capacitance	of	
around	22	pF	and	that	application	of	ZnO	(or	indeed	any	other	NP	type)	did	not	significantly	alter	
Cm.	
Comparison	with	free	Zinc	ions		
It	is	well	known	that	hERG	ion	channels	are	blocked	by	Zn2+[22].		We	applied	a	range	of	ZnCl2	
concentrations	to	voltage-clamped	cells	to	establish	if	the	ZnO	effects	could	be	explained	by	the	
local	release	of	significant	quantities	of	Zn2+	from	the	NPs.		The	results	show	the		ZnCl2	sensitivity	of	
the	hERG	current	where	effects	can		be	detected	between	0.01-20	mM		Zn2+.		Zn2+	has	a	blocking	
effect	with	an	EC50	of	around	800	µM	ZnCl2	(Figure	6	A&B).			
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Significantly,	no	increase	in	steady	state	current	or	tail	current	was	noted	after	addition	of	ZnCl2		
pointing	to	the	mechanism	of	action	of	ZnO	as	being	through		a	nanoparticle-channel	interaction	
rather	than	a	dissolved	free-	ion	channel-	block.		To	further	examine	this	relationship	we	plotted		all	
the	kinetic	parameters	obtained		in	lower	concentrations	of	ZnCl2	against	the	mean	and	SEM	
obtained	in	10	µg/ml	ZnO	(Figure	S8	A-F).	No	significant	effects	of	ZnCl2	were	seen	on	kinetics	that	
were	similar	to	these	seen	on	ZnO	addition.		The	only	significant	alterations	noted	were	a	small	
increase	in	activation	kinetics	in	200	µM	ZnCl2	.	
Coating	ZnO	NPs	and	exposing	membranes	to		serum	protein	
We	hypothesized	that	the	effect	seen	on	addition	of	ZnO	was	a	possible	NP-ion	channel	interaction.		
To	begin	to	investigate	this	we	examined	the	effect	of	coating	ZnO	NPs	with	protein	before	adding	
them	to	the	experimental	chamber.	It	has	been	established	that	exposure	of	ZnO	nanoparticles	to	
serum	proteins	results	in	the	formation	of	a	‘hard’	protein	corona	around		the	particle[17].			10	µg/ml	
ZnO	 nanoparticles	 were	 incubated	with	 1%	 bovine	 serum	 abumin	 (BSA)	 for	 20	minutes	 and	 the	
solution	added	to	the	experimental	chamber.	Recordings	over	20	minutes	revealed	no		alteration	in	
current	 or	membrane	 properties	 (Figure	 S3A).	 Similarly,	 after	 addition	 of	 ZnO	 nanoparticles	 and	
induction	of	the	ZnO	effect,	1%	serum	albumin	was	added	to	the	bath	and	resulted	in	no	reversal	of	
the	 ZnO	 effect	 (Figure	 S3A).	 This	 was	 similar	 to	 the	 lack	 of	 reversal	 of	 the	 ZnO	 effect	 seen	 on	
repeated	washing	(not	shown).		BSA	addition	alone	had	no	effect	on	hERG	currents	(Figure	S3A).			
Influence	of		lipid	peroxidation	
It	has	been	reported	that	exposure	to	10	µg/ml	ZnO	results	 is	 in	significant	 lipid	peroxidation,[18].		
Although	 peroxidation	 takes	 around	 3	 hours	 to	 manifest	 itself,	 and	 here	 experiments	 lasted	 a	
maximum	of	20	minutes,	we	decided	to	test	the	idea		that	the	changes	we	observed	could	be	due	
to	the	early	effects	of	lipid	peroxidation	or	alteration	of	protein	components	in	the	cell	membrane.		
We	exposed	 	 the	cells	 to	0.1%	H2O2	 	 in	extracellular	medium	for	20	minutes	 	while	continuously	
monitoring	membrane	integrity.		We	saw	no	changes	(increases	of	decreases	or	indeed	any	other	
alterations)	in	ion	channel	or	membrane	properties	(Figure	S9).				
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Conclusions	
Nanoparticles		
Our	results	reveal	a	novel	mode	of	nanoparticle-biomembrane	interaction	through	likely	
modification	of	channel	gating	mechanisms	by	ZnO	either	by	direct	interaction	with	the	channel	or	
via	alterations	in	the	properties	of	the	surrounding	lipid	bilayer.	The	data	extend	our	knowledge	of	
nanoparticle	action	by	showing	that	SiO2,	TiO2,	and	MgO	do	not	interact	directly	to	disrupt	the	lipid	
bilayer	or	the	model	K+	channel	(hERG)	used	in	these	studies.		
Nanoparticle	characterization	
Analysis	using	DLS	showed	the	difficulties	in	comparing	the	effects	of	different	NPs	on	cell	
physiology.	While	SiO2	remained	suspended	in	the	test	solution,	ZnO	began	to	aggregate	slowly	
around	20	minutes.	In	comparison,		TiO2	and	MgO	NPs	rapidly	aggregated.		Although	the	former	
particles	had	no	demonstrable	effect	on	the		ion	channel,	any	action	may	have	been		masked	as	the	
rapid	particle	aggregation	presumably	led	to		a	lower	concentration	of	free	particles	available	
around	the	primary	particle	size.	The	problems	of	establishing	what	cells	and	tissue	are	actually	
exposed	to	during	NP	application	have	been	outlined	before	and	are	exacerbated	the	longer	the	
material	is	in	contact	with	NPs	[20].		Equally,	sedimentation	and	aggregation		significantly	alter	dose-
response	relationships	of	NPs	in	culture	conditions,	[11]	and	presumably	contributed	to	the	non-
standard	dose	response	relationship		we	found	between	ZnO	and	hERG.		It	is	well	known	that	the	
continuous	transformation	of	NPs	in	biological	solutions	may	alter	the	outcome	of	toxicological	
experiments.		For	example,		although	TiO2	NPs	are	regarded	as	non-toxic,		they	were	shown	to	
negatively	impact		zebrafish	development[23]	.	When	the	toxicity	of	TiO2	NPs	was	compared	to	their	
dissolved	salt	equivalents	however,		there	was	no	increased	nano-toxicity	effect,	[24].	These	
apparently	conflicting	results	often	occur	when	‘long’	exposures	to	NPs	are	studied.	
Nanoparticle	effects	on	lipid	bilayers	
Bearing	in	mind	the	issues	outlined	above,	combining	DLS	analysis	with	the	hERG		screen			allowed	
us		to	test	rapidly	a	range	of	nanoparticles	on	biological	membranes	and	ion	channels	with	a	
reasonable	certainty	of	their	state	within	the	experimental	time	period.	In	standard	toxicology	
experiments	in	cultured	cell	conditions,	typical	exposure	times	range	from	two	hours	to	several	
days	with	NP	concentrations	ranging	from	10-	100	µg/ml[25].		Our	approach	had	the	advantage	of	
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determining	the	interactions	in	a	matter	of	minutes	and	we	deliberately	tested	particles	at	the	
lower	end	of	the	range	used	in	toxicology	experiments	(from	0.1	to	100	µg/ml).		Our	first	concern	
was	to	determine	the	extent	of	interaction	of	NPs	with	the	lipid	bilayer	of	the	cells.	Under	voltage	
clamp	conditions,	when	a	holding	potential	is	set	(in	this	case	-70	mV),	the	amount	of	current	that	
has	to	be	continuously	injected	into	the	clamp	circuit	to	maintain	this	potential	(termed	holding	or	
leakage	current)	is	a	direct	indication	of	the	membrane	resistance	according	to	Ohms	law.			An	
increased	permeability	of	the	membrane	bilayer	would	be	reflected	by	an	increase	in	this	current	
through	the	clamp	circuit.		This	kind	of	leakage	current	associated	with	nanoparticle-	induced	
nanoscale	‘holes’		has	been	previous	reported	using	the		voltage	clamp	technique[2,4].		This	value	
was	always	used	as	an	initial	(and	continuous)	quality	control	of	the	membrane	state.	Initial	
leakage	currents	after	access	to	the	whole	cell-	mode	of	recording[26]		of	greater	that	-100	pA	were	
rejected	at	the	outset	and	the	current	was	continuously	monitored	during	the	experiment.		We	did	
not	observe	any	changes	in	membrane	holding-current	during	these	experiments	as	a	result	of	the	
addition	of	NPs.		If	anything,	the	quality	of	the	seals	tended	to	gradually	improve	over	the	course	of	
the	experiment	and	this	led	to	some	moderate	changes	(improvements)		in	clamp	quality.		This	lack	
of	change	in	holding	current	does	not	mean	that	nanoparticles	do	not	interact	with	the	surface	of	
the	lipid	bilayer.		Indeed,		in	the	case	of	SiO2,			a	distinct	size	-dependent	Van	der	Waals	interaction	
with	artificial	lipid	monolayers	has	been	reported,		[27]		and	some	formulations		of	ZnO	also	interact	
with	lipid	monolayers	in	the	same	way	(although	the	formulation	we	used	here	of	metals	basis	ZnO	
did	not,	[28]).			The	same	membrane	stability	was	observed	for	MgO		and	TiO2	NPs.		The	close	
contact	of	NPs	with	the	lipid	bilayer	was	reinforced	by	our	results	of	scanning	electron	microscopy	
which	shows	many	particles	on	or	close	to	the	cell	surface.		An	additional	issue	is	that	it	is	known	
that		changes	in	the	local	lipid	environment	have	been	shown	to	alter	hERG	channel	gating	[29]		by	
translocation	of		channels	into	lipid	raft-	like	structures		[30].			Taken	with	recent	work	on	cationic		
nanoparticles,			which		show	that	they	induce	a	local	gel	phase		in	otherwise	liquid	lipid	bilayers[5],		
we	considered	whether		local	lipid	changes	could	contribute	to	the	ZnO	effect.		We	attempted	to	
ascertain	if	the	lipid	environment	was	altered	by	ZnO	NPs	by	measuring	cell	capacitance.		We	found	
no	evidence	of	changes	in	cell	capacitance	after	NP	addition,		however	several	considerations	
indicate	that	the	method	we	used	may	not	be	sensitive	enough	to	definitively	rule	out	local	lipid	
changes.			Previously	it	has	been	shown	in	artificial	lipid	bilayers	that			NP	interactions	with	lipid	can	
be		detected	as	an	increase	in	membrane	capacitance	(Cm).		In	these		experiments,	using		artificial	
black	lipid	bilayers	of	around	150	pF,		addition	of	1	mg/ml	NP	increased	capacitance	by	around	5	%,	
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[21].		In	our	cells	with	a	capacitance	of	20	pF,				and	NP	concentrations	of	10	µg/ml,	we	would	need	
to	be	able	to	resolve	changes	of	less		than		1	pF		and		our	variance	was	around	4-5	pF.		Clearly		on	
this	basis,		we	cannot	rule	out	changes	in	lipid	composition.	
Nanoparticle	effects	on	hERG	channels	
Having	determined	that	membrane	resistance	remained	stable	in	the	range	of	NPs	used	in	these	
experiments,		we	set	up	a	simple	screening	protocol	whereby	the	hERG	channel	current	was	
evoked	by	depolarizing	voltage	steps	to	20	mV	from	the	holding	potential	of	-80	mV	and	resurgent	
tail	currents	were	generated	by	repolarization	to	–50	mV.				These	currents	were	evoked	once	a	
minute	for	20	minutes.			Nanoparticles	were	perfused	over	the	cells	after	7	minutes	of	control	
recording.		Controls	were	also	run	for	20	minutes	for	comparison	without	the	addition	of	NPs	.		The	
results	show	that	under	control	conditions	there	were	no	significant	changes	in	current	amplitudes	
and	currents	were	maintained	for	a	least	20	minutes	without	any	significant	‘rundown’.				No	
changes	in	current	amplitude	were	noted	on	addition	of	SiO2,	TiO2,	or	MgO.			In	contrast	ZnO	
addition	evoked	significant	and	irreversible	changes	in	hERG	current	behaviour.			The	results	from	
the	screening	showed	a	significant	increase	in	current	amplitude	(steady	state)	and	resurgent	tail	
current	peak.				
To	examine	this	effect	of	ZnO	in	more	detail,		a	kinetic	analysis	of	hERG	currents	was	carried	out.		
In	a	separate	series	of	experiments	a	wider	range	of	depolarizing	steps	(between	-30	and	+30	mV		
were	imposed	and		the	results	show	that	there	was	no	underlying	shift	in	voltage	dependence		of	
the	tail	current	(which	could	have	explained	the	increase).			Analysis	of	activation,	inactivation	and	
deactivation	 shows	 that	 while	 activation	 is	 unaffected,	 deactivation	 is	 more	 rapid	 than	 under	
control	 conditions.	 	 	 The	 steady-	 state	 current	 shows	 a	 lesser	 degree	 of	 inactivation	 during	
depolarization	and	this		results	in	less	rectification.		
To	explain	these	changes	we	need	to	examine	hERG	gating.		hERG	channels	have	unusual	gating	
kinetics	where	activation	and	inactivation		have	distinctly	different	rate	constants,		characterized	
by			slow			activation,	fast	inactivation	and	strong	rectification	[31].	This	gives	the	hERG	channel	its	
characteristic	properties		so	crucial	in	its	role	in	controlling			cardiac	action	potential		repolarization	
and	interbeat	stability	[13].			Inactivation	in	K+	channels	can	be		N-type	[32]		or	C-	type	[33]	or	a	
combination	of	both	(where	‘N’	and	‘C	‘refer	to		the	process	of	inactivation	predominantly	
occurring	in	the	regions	of	the	N	and	C	terminals	of	the	channel	protein).		In	hERG	channels	it	
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appears	that	N-type		inactivation	is	absent	or	minimal,	and	C-	type	dominates	[34].			This	means	that	
the	inactivation	mechanism	is	located	in	the	C-	terminal	region	of	the	protein.	The	structural	
determinants	of	inactivation	are	not	located	a	single	part	of	the	protein	but		are			complex	
interactions	between	a	series	of	moieties.		A	recent	summary	(based	on	mutagenesis	scanning	and	
rate	equilibrium	free	energy		relationship	(REFER)	analysis),		indicates	that		this	complex	process	
may	involve		at	last	nine		interconnected	steps,	sequencing	through,		the	loss	of	an	external		K+	,		
from	the	pore	helix	,		the	S5	helix,	the	S5P	linker,		the		S4	helix,	the	S4-S5	linker,	the	S6		helix,	the	
pore	helix		and	the	rearrangement	of	the	channel	selectivity	filter[35].				As	our	results	indicate	that	
ZnO	NPs	are	not	penetrating	the	lipid	bilayer	it	seems	likely	that	they	interact	with	the	external	
face	of	the	channel	either	directly	or	via	alterations	in	the	local	lipid	environment.	Of	the	entities	
described	above	in	the	inactivation	sequence,	only	the	S5P	linker	between	the	S5	and	core	helix	
(P),	and	the	pore	helix	face	the	external	surface	of	the	lipid	bilayer,	and		are	available	to	interact	
with	the	NPs.		
	
The	view		that	the	S5P	linker	could	be	involved	is	supported	by	experiments	where	M-eag	and	
hERG	channel	chimeras	were	made.	M-eag	K+	channels		normally	show	no	inactivation	and	little	
rectification	though	they	are	thought	to	be	closely	related	to	hERG	channels.		Transfer	of	portions	
of	the	hERG	P	region	(core	helix	)	and	half	of	S6		(including	the	S4-S5	linker)	confer	hERG	like	
inactivation	and	rectification	on	M-eag.		While	transfer	of		similar	portions	of	M-eag	to	hERG	
remove	most	of	the	hERG	channels	distinctive		inactivation	and	rectification	[36].			As	the	
rectification	resides	in	the	selectivity	filter	it	seems	likely	that	ZnO	NPs	are	interacting		with	the	
protein	here.	It	would	be	of	great	interest	in	the	future		to	examine	the	effect	of	ZnO	NPs	on	
closely	related	channels	such	as	M-eag	and	on	point	mutations	associated	with		hERG	implicated	
in	arrhythmias	[37]	which	involve	changes	in	the		C	-terminal	region.		Alternatively,	as	movement	of	
hERG	channels	into	lipid-rafts	has	been	shown	to		suppress	currents,	[38]		it	seems	also	possible	
that	movement	out	of	lipid	rafts	could	enhance	currents	in	the	manner	seen		here.		
	
Likely	models	of	action	of	ZnO	
ZnO	is	a	polar	crystalline	‘Wurtzite’	solid	[39]	with	a	tendency	to	aggregate	and	release	Zn2+	in	
solution	[40].		Detailed	kinetic		studies		using	an	electrochemical	method	to	measure	the	free	Zn2+	
concentration	have	shown	that	when	ZnO	is	placed	in	solution,		after	an	initial	release	period,	an	
equilibrium	is	achieved		between	the	ZnO	concentration	and		Zn2+	[41].	At	nearly	neutral	pH,		the	
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ratio	between	bulk	Zn	and	zinc	ions	is	initially	1:0.01	and	rises	after	40	minutes	to	a	steady	ratio	of				
1:0.1	[41].			The	formula	weight	of	the	ZnO	powder	was	81.37	which	means	Zn		was	thus	added	to	
the	cells	at	a	concentration	of	0.123	mM	(10	µg/ml).			Assuming	the	same	solubility	ratios	as	David	
et	al	[41],		this	would	set	the	lower	and	higher	limits	of	Zn2+	in	solution	as	at	1	-12	µM.		It	can	be	
clearly	seen	in	the	scheme	in	Figure	S7	that	this	range	of	Zn2+	has	apparently	no	effect	on	channel	
currents.	At	Zn2+		concentrations	of		0.5	mM	and	above,	channel	block	is	evident	(Figure	6),	as	
previously		described	[22].				It	therefore	also	seems	unlikely	that	hERG	channels	are	modulated	by	
serum	Zn2+	in	this	range.			
Serum	Zn2+	in	adult	humans	is	around	10-17	µM	[42]		and	as	around	80	%	of	Zn		is	bound	to	plasma	
proteins	such	as	albumin,	under	physiological		conditions,	free	zinc	could	be	present	at	no	more	
than	1-2	µM	[43].		The	possibility	remains	however	that	the	presence	of	both	free	Zn2+	and	NPs	in	
very	close	proximity	to	the	channel	are	necessary	for	the	changes	we	observed	in	ion	channel	
currents.		We	were	able	to	partially	test	this	idea	with	the	results		of		the	experiments	where	we	
added	BSA		after	the	channel	effect	had	been	observed.		We	were	unable	to	detect	any	reduction	
in	current	under	these	circumstances.		In	this	situation	BSA	would	have	the	dual	effect	of	binding	
to	available	free	NPs	and	absorbing	free	Zn2+.			In	experiments	where	ZnO	NPs	were	mixed	with	
BSA	prior	to	addition	to	the	experimental	chamber,		the	NP	effect	was	neutralized	completely.	
These	considerations	effectively	rule	out	the	possibility	that	the	effect	seen	on	hERG	K+	currents	
can	be	attributed	to	a	significant	accumulation	of	Zn2+	at	the	surface	of	the	particle	or	in	the	bulk	
solution	and	point	to	a	likely	nano-membrane	protein/lipid	interaction.			
Thus	the	likely	mode	of	action	on	channel	gating	is	either	through	a	direct		interaction	with	the	ZnO	
nanoparticle	or	through	an	interaction	with	the	lipid	environment	of	the	hERG	channel.			Two	
opposing	forces	determine	the	stability	and		fixed	charge	of			NPs	in	solution;	electrostatic	repulsion	
vs.	Van	der	Waals	forces	[44]		(described	by		DLVO		theory:	Derjaguin,	Landau,	Verwey	and	Overbeek).		
As	ZnO	has	an	isoelectric	point	between	9-10		the	NPs	will	have	a	strong	positive	charge	at	physiological	
pH	[45],	however	this	charge	will	be	screened	in	bulk	solutions	by	counter	ions	(this	is	seen	in	Table	1	
where	the	Zeta	potential		becomes	nearly	neutral	in	hERG	solution).		NPs	will	be	able	to	exert	an	effect	
only	at	interfaces	especially	if	negatively	charged	elements	are	encountered	which	can	replace	the	bulk	
counter	ions,	and	where	Van	der	Walls		forces	rather	than	opposing,		will	combine	in	relatively	strong	
interactions.	Such	interactions	with	gating	in	biological	membranes	have	been	shown	to	be	
theoretically	feasible	[46].		Again	if	we	consider	the	outwardly	facing	S5P	loop	of	the	hERG	channel	that	
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is	so	critical	in	inactivation	in	hERG	(see	above),			it	has	been	found	that	substitution	of	negatively	
charged	Aspartate	(D)	at	position	591	with		positively	charged	Arginine	(R)		enables	reduced	
inactivation	of	the	current	in	much	the	same	way	as	we	see	here	[47].		It	seems	possible	that	a	closely	
opposed	positively	charged	NP	could	neutralise	(and	perhaps	weakly	bind	to),	the	negatively	charged	
residue.	It	would	be	of	great	interest	to	see	if	modifications	of	the	surface	charge	on	ZnO	and/or		
mutations	of	position	591	could	alter	this	result.			
Irreversibility	and	dose	dependence	
We	would	like	to	underline	the	finding	that	we	were	unable	to	reverse	the	ZnO	effect	even	after	20-40	
minutes	of	continuous	washing	with	fresh	hERG	solution.		This	suggests	that	the	interaction	with	NP	is	
irreversible	and	points	to	either	a	transformation	in	the	lipid	bilayer	or	binding	to	the	channel.		We	also	
tried	to	establish	 the	dose	response	relationship	between	ZnO	and	the	 increase	 in	 the	hERG	current.	
The	data	was	not	well	fit	with	a	dose	response	curve	though	it	was	clear	that	the	effect	increased	with	
increasing	 concentration.	 	 This	 experiment	was	 problematic	 because	 of	 the	 lack	 of	wash-off	 and	 	 as	
many	of	the	seals	became	unstable	at	>100	µg/ml.		
Cardiac	risk	
Considering	the	importance	of	hERG	in	controlling	cardiac	beat	stability,	this	finding	has	
implications	for	the	choice	of	NPs	to	be	used	in	biomedicine	which	is	a	rapidly	a	growing	field	[48].		
In	the	first	instance	alterations	in	hERG	channel	conductance	in	the	range	shown	here	by	modest	
concentrations	of	ZnO	NPs	could	alter	the	cardiac	action	potential	and	subsequent	contractility	by	
decreasing	the	intracellular	Ca2+	transient.		Thus	ZnO	may	be	considered	to	represent	a	cardiac	risk	
factor	if	used	in	formulations	(though	increasing	the	hERG	current	effectively	increases	beat	
stability).		ZnO	is	normally	considered	to	be	relatively	harmless	and	is	used	regularly	in	e.g		
fluorescence,			magnetic	resonance,	and	positron	emission	tomography	imaging	as	well	as	in	
topical	and		systemic	application	[48].		In	our	experiments,	ZnO	altered	channel	gating	when		protein	
free	media	was	used,	the		protein	‘corona’	which	rapidly	forms		around	NPs	(including	ZnO)	when	
serum	containing	media	is	used	[17,49],	negated	this	effect.			It	seems	likely	that		the	protein	coating	
would	screen	any	charge	effects	or	binding	seen	in	our	experiments.			We	were	unable	to	reverse	
the	effects	seen	on	hERG	with	long-term	washing	(up	to	two	hours)		and	thus	is	seems	possible	
that	there	is	an		irreversible	interaction	with	the	channel	protein	or	the	lipid	bilayer.	Further	
experimentation	with	higher	resolution	Cm	measurements	will	be		required	to	establish	which	of	
the	two	mechanisms	are	most	likely	and		thus	reach	a	conclusion	on	the	potential	risk	to	cardiac	
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health	including	experiments	with	cardiomyocytes.		Finally	it	is	worth	noting	there	are	few	drugs	
designed	to	work	on	the	hERG	current	that	act	to	increase	the	current	density	on	depolarization.	
The	vast	majority	of	compounds	known	to	interact	on	hERG	do	so		to	block	or	inhibit	channel	
activity	and	are	thus	not	particularly	useful	in	rectifying	hERG	current	deficiencies	that		lead	to	
arrhythmias	[13,50].				
Conclusions	
Through	screening	a	panel	of	nanoparticles	against	bio-membranes	and	a	model	K+	ion	channel,	we	
show		that	most	NPs	do	not	interact	with	either	membrane	or	channel.	However,	ZnO	nanoparticles	
exhibit	a	strong	effect	on	channel	gating	such	that	the	hERG	channel	loses	some	of	its	normally	
strong	rectification.	The	results	suggest	that	this	is	mediated	though	a	novel	ion	channel	-NP	
interaction.		
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Figures	and	Figure		legends	
	
	
Figure	1.	Diagram	of	the	experimental	setup.	Solutions	(including	nanoparticles)	were	perfused	
over	cultured	HEK	239	cells	expressing	hERG	potassium	channels	(green		symbols).	Cells	were	
voltage	clamped	through	glass	micropipettes	via	a	feedback	amplifier	(FBA).	Current	(I)	was	
measured	as	was	electrical	potential	(E).	Command	potentials	were	applied	to	the	FBA	circuit	to	
evoke	membrane	currents.	The	internal	environment	of	the	cell	was	also	rapidly	dialyzed	through	
the	pipette	with	a	K+	-rich	solution.	
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Figure	2.	Current/voltage	relations	of	hERG	currents	in	HEK239	cells.	A)	Voltage	clamp	protocol.	
The	holding	potential	was	-70	mV.	A	brief	5	mV	depolarizing	pulse	to	check		leakage	and	capacitive	
currents	was	followed	by		12	x		depolarizing	10	mV	incremental	steps	to	+80	mV.		After	5	seconds	
depolarization	the	potential	was	stepped	to	-50	mV.		The	currents	evoked	show	two	main	
characteristics:		a	slow	outward	current	that	inactivates	strongly	during	increasingly	positive	
depolarizations	and	a	prominent	resurgent	tail-currents	on	repolarization	to	-50	mV.			B)		Current-	
voltage	relations	of	the	currents	in	A).		The	outward	tail	currents	measured	at	their	peak	(n)	show	
a		perfect	Boltzmann	-like		relationship	which	was	well	fit	by	the	formula	(black	curve):		normalized	
tail	current=	1/{1	+exp((V0.5-)/K)}.	V0.5	was	-0.8	mV	and	K	was	mV	7.6	(slope	factor)	in	this	case	(for	
average	values	see	the	legend	of		Figure	S9).		
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Figure	3.		Nanoparticle	addition		and		hERG		peak	resurgent	tail-	currents.	First	and	last	of	twenty	
currents	evoked		at	one		minute	intervals	from	a	holding	potential	of	-70	mV,	stepped	to	+20	mV	
and	repolarised	to	-50	mV	before	stepping	back	to	-70	mV.		A)	Addition	of	10	µg/ml			of	SiO2,		B)	
Peak	tail	currents	evoked	by	the	pulse	protocol	in	A).		Tail	currents	are	plotted	against	
experimental	time	(20	minutes)	as	the	average	and	standard	error	of	the	mean	(SEM).			Six	
experiments	where	SiO2		was	added	on	the	seventh	pulse	(n	,	SiO2	addition	shown	by	the	red	bar)	
are	plotted	against	six		control	(no	addition,	●)	to	show	the	stability	of	the	preparation.	C)				
Example	of	first	and	last	currents	under	the	same	conditions	as	A	showing	the	effect	of	10	µg/ml	
ZnO	addition		D)	Peak	tail	currents	evoked	by	the	pulse	protocol	in	A).		Tail	currents	are	plotted	
against	experimental	time	(20	minutes)	as	the	average	and	standard	error	of	the	mean	(SEM).			Six	
experiments	where	ZnO	was	added	on	the	seventh	pulse	(n)	are	plotted	against	six		controls	(no	
addition	●	).	Samples	from	12-20	minutes	are	significantly	different	(P<0.05).	
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Figure	4.		Nanoparticle	effects	on	‘steady	state’	hERG			currents.	First	and	last	of	twenty	hERG	
currents	evoked		at	one		minute	intervals	from	a	holding	potential	of	-70	mV,	stepped	to	+20	mV	
and	repolarised	to	-50	mV	before	stepping	back	to	-70	mV.		A)	Addition	of	10	µg/ml		of	ZnO.	B)	
Currents	evoked	by	the	pulse	protocol	in	A).		Currents	are	plotted	against	experimental	time	(20	
minutes)	as	the	average	and	standard	error	of	the	mean	(SEM).					Six	experiments	where	ZnO	was	
added	on	the	seventh	pulse	(n,	ZnO	addition	shown	by	the	red	bar)	are	plotted	against	six		control	
(no	addition,	●	)	to	show	the	stability	of	the	preparation.	
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Figure	5.		ZnO	action	on		the	inactivation	rate	of	the	resurgent	tail	current.				A)	A	double	
exponential	functions	were	fitted	to	tails	of	the	resurgent	tail-		currents.		B)	and	C).	The	fast	and	
slow	inactivation	time	constants		were		plotted	against	experimental	time	(20	minutes)	as	the	
average	and	standard	error	of	the	mean	(SEM)	of	six	experiments	where	ZnO	was	added	on	the	
seventh	pulse	(n,	also	shown	by	the	red	bar).	Mean	and	SEM	of	six		controls	(no	addition		●		).	
Samples	from	11-20	minutes	are	significantly	different	(P<0.05).	
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Figure	6	
Figure	6.		ZnCl2		and		hERG	resurgent	tail	currents.		Currents	were	evoked		at	one		minute	intervals	
from	a	holding	potential	of	-70	mV,	stepped	to	+20	mV	and	repolarised	to	-50	mV	before	stepping	
back	to	-70	mV.		A)	Addition	of	1	mM	ZnCl2	suppressed	steady	state	and	tail	currents.		B)	Addition	
of	a	range	of	ZnCl2	concentrations	(10	μM	-10	mM)	progressively	suppressed	the	tail	current.		The	
data	was	well	fit	by	a	two	state	Boltzmann	function	with	a	half	block	at	890	μM	(red	line).	
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Table	1	.	Table	showing	the	physical	dimensions	and	Zeta	potential	(charge)		of	nanoparticles	used	
in	this	study.		Nanoparticle	primary	particle	diameter	was	that	provided	by	the	manufacturers	
while	particle	size	was	estimated	from	DLS	and	SEM	images	(in	the	case	of	SiO2,	ZnO,	and	TiO2	
column	7)	ND=	not	done.				
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Figure	S1.	LAL	chromogenic	assay	results	showing	standard	curve	(dotted	red	line)		fit	to	endotoxin	
standards	 (●).	 	The	mean	values	of	endotoxin	 in	 	NPs	samples	at	a	concentrations	of	10	ug/ml	 in	
hERG	 solution	 are	 shown.	 	 Blue,	 TiO2,	 green,	MgO2,	 Black	 ZnO	Blue	 SiO2.	Mean	 and	 SD	 of	 three	
independent	measurements.		
Accepted	version.		Published	online	in	Small	26	February	2018																																																																								DOI	10.1002/smll.201703403	
32	
	
	
200	nm
	
A	
A’	
1	
µm
	
20
0	
nm
	
A	 B	 C	 D
	
A’
	
B’
	 C’
	
D’
	
Figure	S2	
	
	
Figure	S2.	SEM	of	HEK239	cells	in	the	presence	of	nanoparticles	A,	A’	controls	(no	nanoparticles),	B,		
B’	 SiO2	 NPs,	 C	 C’	 ZnO	 NPs	 (Metal	 Basis),	 D,	 D’	 	 TiO2	 NPs.	 	 Scale	 bars	 are	 1	 µM	 and	 200	 nm	
respectively.	White	arrows	show	a	continuous	covering	of	SiO2	particles	 in	B’	covering	 the	entire	
surface	of	the	cell,		individual	ZnO	crystals	in	C’	and	clusters	of	small	spherical	TiO2	particles	in	D’.		
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Figure	S3.	Summary	of	results	from	the	screening	of	nanoparticles		and	the	effect	of	coating	ZnO	
with	 BSA	 against	 hERG	 currents.	 	 	 Results	 show	 the	 average	 of	 at	 least	 six	 experiments	 per	
condition.	 	 	hERG	currents	were	evoked		at	one		minute	 intervals	from	a	holding	potential	of	-70	
mV,	stepped	to	+20	mV	and	repolarised	to	-50	mV	before	stepping	back	to	-70	mV.		A,		tail	current	
amplitudes	were	measured	before	and	after	addition	of	NPs.	All	NPs	were	added	at	10	µg/ml.	The	
ZnO	sample	is	significantly	different	from	the	control	sample	(P<0.05).		Adding	BSA	after	induction	
of	the	ZnO	effect	did	not	reverse	the	increase	in	current.	B,	concentration	ranges	of	ZnO	NPs	and	
their	effects	on		hERG	tail	currents.			
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Figure	 S4.	 The	 effect	 of	 ZnO	 on	 activation	 of	 the	 hERG	 current.	 	 A)	 Examples	 of	 hERG	 currents	
evoked	 	 at	 one	 	 minute	 intervals	 from	 a	 holding	 potential	 of	 -70	 mV,	 stepped	 to	 +20	 mV	 and	
repolarised	to	-50	mV	before	stepping	back	to	-70	mV.	The	example	shows	the	first	and	last	current	
after	addition	of	ZnO.	The	activation	was	estimated	by	fitting	the	first	500	ms	of	the	‘steady-state’	
currents	with	a	single	exponential	function	(see	text).		B)	Plot	of	the	time	constant	of	activation	of	
hERG	 in	 the	 presence	 and	 absence	 of	 ZnO	 over	 20	minutes.	 	 	 Results	 show	 the	 average	 of	 	 six		
control	(n)	and	six		experiments	where	ZnO	was	added.		
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Figure	S5.		A)	Examples	of	the	effect	of	the	addition	of	nanoparticles		on		the	inactivation	rate	of	the	
steady	state	hERG	current.		A	straight	line	was	fitted	to	the	currents	one	second	after	initiation	of	
the	steady	state	current	and	the	slope	of	the	line	plotted.		B)		Plot	of	the	slope	of	the	lines	plotted	
against	 time.	 	 	 Currents	 are	 plotted	 against	 experimental	 time	 (20	minutes)	 as	 the	 average	 and	
standard	error	of	the	mean	(SEM)	of	six	experiments	where	ZnO	was	added	on	the	seventh	pulse	(
,	also	shown	by	the	red	bar).	The	data	are		plotted	against	the	mean	and	SEM	of	six		controls	(no	
addition	 ).		
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Figure	S6.	ZnO	does	not	alter	the	current/voltage	relations	of	the	steady	state	or	tail	currents.	A)		
and	B),	examples	of	whole-cell	hERG	currents	before	and	during	exposure	to	10	µg/ml	ZnO.	There	is	
an	 obvious	 increase	 in	 current	 as	 a	 result	 of	 ZnO	 at	 all	 voltages.	 	C)	 Plot	 of	 tail	 	 currents	 versus		
voltage	 in	 ten	 	 experiments	 (Mean	 +/-	 SEM).	 	 The	 results	 show	 that	 both	 tail	 and	 steady-	 state	
currents	increase	proportionately	at	all	voltages	and	there	is	no	voltage	shift	in	the	peak	current	on	
ZnO	addition.	V0.5		was	-4.6+/-	0.42		in	controls	and	-4.2	+/-	1.12	mV	on	addition	of	ZnO	NPs,		while		
the	slope	function	of	the	Boltzmann	fit	was	12.36+/-0.56	and	13	+/-	1.6	mV	respectively.			
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Figure	S7.		Membrane	capacitance	measured	before	and	during	ZnO	NP	application.			The	black	
squares	represent	mean	and	error	bars	+/-		SEM	of	6	experiments.			No	significant	differences	in	
membrane	capacitance	were	detected.	
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Figure	S8	The	effect	of		low	concentrations	of	ZnCl2		on	hERG		currents	compared	to	the	effect	of		10	
µl/ml	 ZnO.	 	 The	 black	 squares	 represent	 mean	 and	 SEM	 of	 5	 experiments	 in	 different	
concentrations	of	ZnCl2	(from	1-300	µM).		The	blue	and	red	boxes	represent	the	extent	of	variance	
(SEM)	 and	 mean	 (red	 line)	 envelopes	 of	 control	 and	 in	 the	 presence	 of	 ZnO	 respectively.	 	 All	
currents	were	evoked			at	one	minute	intervals	from	a	holding	potential	of	-70	mV,	stepped	to	+20	
mV	and	repolarised	to	-50	mV	before	stepping	back	to	-70	mV.		A)	Peak	resurgent	tail	current,	B)	
peak	 steady	 state,	 C)	 activation	 	 time	 constant	 of	 hERG	 current,	D)	 Slow	 tail	 deactivation	 time	
constant,	E)	Fast	tail	deactivation	time	constant,	F)	slope	of	steady	state	current.		
Accepted	version.		Published	online	in	Small	26	February	2018																																																																								DOI	10.1002/smll.201703403	
39	
	
control 0.1%H2O2
0
200
400
600
15 10 5 
Time (s) 
Im
em
b 
(p
A
) 
0 
1000 
2000 
15 10 5 
Time (s) 
Control	 0.1%	H2O2	
20	mins	0.1%	H2O2	
A	 B	
Figure	S9	
	
Figure	S9.	H2O2	 	 exposure	does	not	 alter	 the	 current/voltage	 relations	of	 the	 steady	 state	or	 tail	
currents.	A),			examples	of	whole-cell	hERG	currents	before	and	during	exposure	to	0.1%		H2O2	(20	
mins).	 	 There	 is	 a	 slight	 ‘rundown’	 	 of	 the	 whole-cell	 current	 over	 20	 minutes	 and	 no	 obvious	
increase	in	current	as	a	result	of	H2O2	exposure.		B)	Plot	of	the	steady	state	currents	at	+20	mV		in	
four		experiments	(Mean	+/-	SEM).		The	results	show	that		steady-	state	currents	were	not	altered	
in	the	short	term	by	exposure	to	peroxidation.	
